Verona Pharma PLC (VRNA)
35.66
+0.29
(+0.82%)
USD |
NASDAQ |
Nov 15, 16:00
35.69
+0.03
(+0.08%)
After-Hours: 20:00
Verona Pharma Revenue (Annual)
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.458M |
| Date | Value |
|---|---|
| December 31, 2021 | 40.00M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.458M
Minimum
2022
40.00M
Maximum
2021
20.23M
Average
20.23M
Median
Revenue (Annual) Benchmarks
| Biodexa Pharmaceuticals PLC | 0.4741M |
| TC BioPharm (Holdings) PLC | -- |
| Adaptimmune Therapeutics PLC | 60.28M |
| NuCana PLC | -- |
| Autolus Therapeutics PLC | 1.698M |